Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of asthma and allergy
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile
J Asthma Allergy 2022 Aug 01;15(2022)565-577, P Rogliani, F Cavalli, A Chetta, M Cazzola, L CalzettaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.